Epsilen Bio Company
Epsilen Bio is developing a transformative therapy known as Epigenetic Silencing to treat human diseases.
Founded Date:
2019
Last Funding Type:
Seed
Headquarters:
Milan, Lombardia, Italy
Investors Number:
1
Technology:
Immunotherapy
Employee Number:
1-10
Industry:
PharmTech
Funding Status:
Seed
Investor Type:
For Profit